171231-75-7

Upstream product

• 49747-05-9 endo-2,endo-4-Dimethyl-8-oxabicyclo<3.2.1>oct-6-en-3-on 
• 96691-93-9 (1R,2R,3r,4S,5S)-2,4-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-ol 
• 760978-01-6 endo-3-benzyloxy-endo,endo-2,4-dimethyl-8-oxabicyclo-[3.2.1]-octan-6-one 
• 100-39-0 benzyl bromide 
• 171231-74-6 (1S,2R,3R,4R,5S,6R)-3-Benzyloxy-2,4-dimethyl-8-oxa-bicyclo[3.2.1]octan-6-ol 
• 96691-92-8 (1R,2R,3r,4S,5S)-3-(benzyloxy)-2,4-dimethyl-8-oxa-bicyclo[3.2.1]oct-6-ene 

Downstream Products

• 359868-22-7 (3S,4R,5S,6S)-5-(benzyloxy)-4,6-dimethylheptane-1,3,7-triol 
• 359868-27-2 ((2S,3S,4S,5S)-4-Benzyloxy-3,5-dimethyl-6-oxo-tetrahydro-pyran-2-yl)-acetaldehyde 
• 359868-26-1 (3R,4R,5S,6S)-5-Benzyloxy-4,6-dimethyl-heptane-1,3,7-triol 
• 359868-28-3 (3S,4S,5S,6S)-4-Benzyloxy-6-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-3,5-dimethyl-tetrahydro-pyran-2-one 
• 359868-25-0 (3R,4R,5S,6S)-5-Benzyloxy-1,7-bis-(tert-butyl-diphenyl-silanyloxy)-4,6-dimethyl-heptan-3-ol 
• 359868-23-8 (3S,4R,5S,6S)-5-Benzyloxy-1,7-bis-(tert-butyl-diphenyl-silanyloxy)-4,6-dimethyl-heptan-3-ol 
• 359868-24-9 (4S,5S,6S)-5-Benzyloxy-1,7-bis-(tert-butyl-diphenyl-silanyloxy)-4,6-dimethyl-heptan-3-one 
• 1360170-36-0 (((3S,4S,6R)-7-(methoxymethoxy)-4,6-dimethylheptan-3-yloxy)methyl)benzene 
• 1360170-07-5 (2R,4S,5S)-5-(benzyloxy)-2,4-dimethylheptan-1-ol 
• 1360170-65-5 (4R,6S,7S)-7-(benzyloxy)-4,6-dimethylnonan-3-one 
• 1360170-67-7 (3R,5S,6S)-6-(benzyloxy)-3,5-dimethyloctan-2-one 
• 1360170-20-2 (S)-4-((2R,3S,4S)-3-(benzyloxy)-5-(methoxymethoxy)-4-methylpentan-2-yl)-2,2-dimethyl-1,3-dioxane 
• 1360170-70-2 C₁₈H₃₀O₂ 
• 72522-40-8 (4R,6S,7S)-7-hydroxy-4,6-dimethyl-3-nonanone 

Relevant academic research and scientific papers

Total synthesis of (-)-invictolide

A convergent approach to the total synthesis of (-)-invictolide, a component of the queen recognition pheromone of Solenopsis invicta, is described. Key steps involve the desymmetrization of a bicyclic olefin with Brown's chiral hydroboration, C-C bond fo

Towards the synthesis of (+)-discodermolide

An approach to the asymmetric synthesis of fragments corresponding to C1-C7 and C15-C24 of (+)-discodermolide is reported. Key elements of the successful strategy include elaboration of two advanced fragments from a common precursor.

Asymmetric Synthesis of C-19 to C-27 Fragment of Rifamycin-S

A highly stereoselective asymmetric synthesis of C-19 to C-27 fragment of Rifamycin-S consisting of 7 contiguous asymmetric centres is described involving Ipc2BH as the chiral hydroborating reagent.